James Abbruzzese, MD

Professor of Medicine
D. C. I. Professor of Medical Oncology
Chief, Division of Medical Oncology
Member of the Duke Cancer Institute
Campus mail 440 Mudd Building, Box 3406, Durham, NC 27710
Email address james.abbruzzese@duke.edu

My research interests include the clinical study and treatment of pancreatic cancer.

In Their Words

Education and Training

  • Resident, Internal Medicine, Johns Hopkins University School of Medicine, 1979 - 1981
  • Intern, Internal Medicine, Johns Hopkins University School of Medicine, 1978 - 1979
  • M.D., University of Chicago, 1978

Publications

Zhang, Tian, Rengasamy Boominathan, Brad Foulk, Chandra Rao, Gabor Kemeny, John H. Strickler, James L. Abbruzzese, et al. “Development of a Novel c-MET-Based CTC Detection Platform..” Mol Cancer Res 14, no. 6 (June 2016): 539–47. https://doi.org/10.1158/1541-7786.MCR-16-0011.

PMID
26951228
Full Text

Overman, M. J., V. Morris, B. Kee, D. Fogelman, L. Xiao, C. Eng, A. Dasari, et al. “Utility of a molecular prescreening program in advanced colorectal cancer for enrollment on biomarker-selected clinical trials..” Ann Oncol 27, no. 6 (June 2016): 1068–74. https://doi.org/10.1093/annonc/mdw073.

PMID
27045102
Full Text

Parsons, Henrique A., Vickie E. Baracos, David S. Hong, James Abbruzzese, Eduardo Bruera, and Razelle Kurzrock. “The effects of curcumin (diferuloylmethane) on body composition of patients with advanced pancreatic cancer..” Oncotarget 7, no. 15 (April 12, 2016): 20293–304. https://doi.org/10.18632/oncotarget.7773.

PMID
26934122
Full Text

Li, Donghui, Jennifer Moughan, Christopher Crane, John P. Hoffman, William F. Regine, Ross A. Abrams, Howard Safran, et al. “RECQ1 A159C Polymorphism Is Associated With Overall Survival of Patients With Resected Pancreatic Cancer: A Replication Study in NRG Oncology Radiation Therapy Oncology Group 9704..” Int J Radiat Oncol Biol Phys 94, no. 3 (March 1, 2016): 554–60. https://doi.org/10.1016/j.ijrobp.2015.10.062.

PMID
26725729
Full Text

Raghav, Kanwal Pratap Singh, Sminil Mahajan, James C. Yao, Brian P. Hobbs, Donald A. Berry, Rebecca D. Pentz, Alda Tam, et al. “From Protocols to Publications: A Study in Selective Reporting of Outcomes in Randomized Trials in Oncology..” J Clin Oncol 33, no. 31 (November 1, 2015): 3583–90. https://doi.org/10.1200/JCO.2015.62.4148.

PMID
26304898
Full Text

Lu, W., Y. Yang, Y. Luo, Y. Liu, X. Wang, M. Liu, R. A. Wolff, J. L. Abbruzzese, and C. D. Logsdon. “FGF21 Delays Pancreatic Cancer Formation and Prevents Liver Metastasis in Oncogenic Kras Expressing Mice Fed on High-Fat Diet.” Pancreas 44, no. 8 (November 1, 2015): 1393–1393.

Scholars@Duke

Li, Donghui, Mayurika N. Pise, Michael J. Overman, Chang Liu, Hongwei Tang, Saroj Vadhan-Raj, and James L. Abbruzzese. “ABO non-O type as a risk factor for thrombosis in patients with pancreatic cancer..” Cancer Med 4, no. 11 (November 2015): 1651–58. https://doi.org/10.1002/cam4.513.

PMID
26275671
Full Text

Fogelman, David, Elizabeth A. Sugar, George Oliver, Neeraj Shah, Alison Klein, Christine Alewine, Huamin Wang, et al. “Family history as a marker of platinum sensitivity in pancreatic adenocarcinoma..” Cancer Chemother Pharmacol 76, no. 3 (September 2015): 489–98. https://doi.org/10.1007/s00280-015-2788-6.

PMID
26126726
Full Text

Pages